Xponential Fitness completes divestiture of Lindora to Next Health

Xponential Fitness (XPOF) completed the divestiture of its Lindora brand to Next Health Management Group, a strategic move to focus resources on more profitable core fitness modalities. This follows a Q2 2025 report where the company exceeded adjusted EPS expectations ($0.26 vs. $0.22 forecast) but slightly missed revenue targets ($76.2M vs. $77.24M), primarily due to lower equipment sales. Despite InvestingPro suggesting the company is undervalued with 67.5% gross profit margins, XPOF also announced the departure of its North America President and the appointment of Rachel Lee to its Board, with Stifel maintaining a Hold rating and a $12 price target.

Analysis

Xponential Fitness (NYSE:XPOF) has completed the strategic divestiture of its Lindora brand to focus resources on its core, higher-profitability fitness modalities. This corporate restructuring follows a mixed second-quarter 2025 earnings report, where the company surpassed adjusted EPS expectations at $0.26 versus a $0.22 forecast, but missed revenue targets, reporting $76.2 million against an anticipated $77.24 million. The slight year-over-year revenue decrease was attributed to lower equipment sales, though this was partially mitigated by growth in franchise revenue. Despite this, the company maintains a strong gross profit margin of 67.5% on last-twelve-months revenue of $316.8 million, and is considered undervalued by some external analyses. Concurrent with the divestiture, XPOF announced significant leadership changes, including the departure of its President of North America and the appointment of Rachel Lee, an experienced finance professional, to its Board of Directors. Stifel's maintained 'Hold' rating and $12 price target on the stock, which currently trades at $8.20, reflects a cautious but potentially positive outlook, balancing the strategic streamlining against recent revenue softness and management uncertainty.

Key Decisions for Investors

• Investors should view the Lindora divestiture as a positive strategic pivot toward higher-margin core operations, but must monitor upcoming quarters for tangible improvements in profitability and franchise revenue growth.
• The combination of a Q2 EPS beat and high gross margins (67.5%) is bullish, but this is tempered by a revenue miss and the unexplained departure of a key executive, warranting a cautious stance consistent with Stifel's 'Hold' rating.
• With the stock at $8.20, Stifel's $12 price target suggests potential upside, and investors may consider the stock's reported undervaluation as an opportunity, while remaining mindful of the execution risks associated with the recent revenue softness and leadership transition.